Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Hepatitis C treatment

Here Is Why Gilead Sciences, Inc. Is Still Doing Better Than AbbVie Inc

Editor's pick
Bidness
10 March 2015
Access to healthcare

$10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh

Editor's pick
Bloomberg
9 March 2015
Access to healthcare

EECA CAB positions in regards to Janssen, BMS, Gilead and ViiV policy

Editor's pick
EATG
9 March 2015
Hepatitis C treatment

Natco Pharma ties up with Gilead on hepatitis C drugs

Editor's pick
Reuters
4 March 2015
PrEP

PrEP Access For HIV Prevention In Australia A Step Closer As Gilead Applies To TGA

Editor's pick
Star Observer
3 March 2015
Pharmaceutical industry

Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

Editor's pick
Chicago Tribune
27 February 2015
PrEP

HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

Editor's pick
EATG
25 February 2015
Access to healthcare

Merck places children's HIV drug in shared non-profit patent pool

Editor's pick
Reuters
24 February 2015
Hepatitis C treatment

amfAR Report Examines Controversial Pricing of Hepatitis C Treatment

Editor's pick
amfAR
19 February 2015
Pharmaceutical industry

The Drug That Is Bankrupting America

Editor's pick
Huffington Post
18 February 2015
Pharmaceutical industry

Patient groups rank ViiV Healthcare #1 in corporate reputation survey, again

Editor's pick
Bio Pharma Dive
16 February 2015
Pharmaceutical industry

How ViiV Healthcare became a pharma favorite for patient groups

Editor's pick
BioPharma Dive
16 February 2015
Pharmaceutical industry

Healthcare: The race to cure rising drug costs

Editor's pick
Financial Times
13 February 2015
New & experimental hepatitis C treatment

FDA revokes breakthrough status for BMS hep C drug

Editor's pick
Fierce Biotech
11 February 2015
Pharmaceutical industry

Dutrebis, New HIV Drug, Approved by FDA, but Not Commercially Available

Editor's pick
The Body Pro
11 February 2015
Men who have sex with men (MSM)

ViiV Launches $10M Initiative to Fight HIV Among Black MSM

Editor's pick
Poz magazine news
6 February 2015
Pharmaceutical industry

GlaxoSmithKline seeks advice on floating HIV division

Editor's pick
The Guardian
5 February 2015
Hepatitis C treatment

What the 'Shocking' Gilead Discounts on its Hepatitis C Drugs Will Mean

Editor's pick
Wall Street Journal (blog)
5 February 2015
Hepatitis C treatment

Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion

Editor's pick
New York Times
5 February 2015
Hepatitis B

Hepatitis Quest Moves From C to B Under Former Gilead Executives

Editor's pick
Bloomberg
5 February 2015
New & experimental hepatitis C treatment

Merck says hepatitis C drugs to lose breakthrough status

Editor's pick
Reuters
5 February 2015
Access to healthcare

Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries

Editor's pick
TAG
3 February 2015
Pharmaceutical industry

AbbVie Inc stock drops after expectations for Viekira Pak fall short

Editor's pick
Bidness Etc
2 February 2015
Access to healthcare

Hepatitis C drug access: Europe is the new Africa

Editor's pick
HIV i-Base
30 January 2015